When it comes to long-lasting protection against COVID-19, antibodies — proteins created by B cells to neutralize invading pathogens — are our biggest allies, a new Yale study shows.
More
British Reporter — The second dose of the Pfizer COVID-19 vaccine produced a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks, in people over 80, according to UKRI.
More
British Reporter — COVID infection in patients with antibody deficiency (COVAD) is part of a portfolio of national studies examining the immune responses in patients at high risk of COVID-19.
More